Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland.
J Biol Chem. 2013 Aug 2;288(31):22576-83. doi: 10.1074/jbc.M113.453159. Epub 2013 Jun 10.
A representative of a new class of potent antimalarials with an unknown mode of action was recently described. To identify the molecular target of this class of antimalarials, we employed a photo-reactive affinity capture method to find parasite proteins specifically interacting with the capture compound in living parasitized cells. The capture reagent retained the antimalarial properties of the parent molecule (ACT-213615) and accumulated within parasites. We identified several proteins interacting with the capture compound and established a functional interaction between ACT-213615 and PfMDR1. We surmise that PfMDR1 may play a role in the antimalarial activity of the piperazine-containing compound ACT-213615.
最近描述了一种具有未知作用模式的新型强效抗疟药物代表。为了确定这类抗疟药物的分子靶标,我们采用光反应亲和捕获方法在活寄生细胞中寻找与捕获化合物特异性相互作用的寄生虫蛋白。捕获试剂保留了母体分子(ACT-213615)的抗疟特性,并在寄生虫内积累。我们鉴定了与捕获化合物相互作用的几种蛋白质,并确定了 ACT-213615 与 PfMDR1 之间的功能相互作用。我们推测 PfMDR1 可能在含哌嗪的化合物 ACT-213615 的抗疟活性中发挥作用。